Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
09/24/2002 | US6455704 Reacting carbazole with butyllithium in hydrocarbon solvent forming intermediate, then reacting with potassium butoxide |
09/24/2002 | US6455587 Aromatic sulfonyl derivatives |
09/24/2002 | US6455581 Inhibitors of hiv protease. |
09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
09/24/2002 | CA2246584C Method of treating tourette's syndrome |
09/24/2002 | CA2096223C Treatment for tissue ulceration |
09/20/2002 | WO2001070687A1 Indoles for treating diseases that can be treated using thyroid hormones |
09/20/2002 | CA2403806A1 Indoles for treating diseases that can be treated using thyroid hormones |
09/19/2002 | WO2002072549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
09/19/2002 | WO2002072548A2 Heterocyclic compounds and their use as histamine h4 ligands. |
09/19/2002 | WO2002072547A1 Amination process |
09/19/2002 | WO2002072532A1 7, 9-substituted tetracycline compounds |
09/19/2002 | WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes |
09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
09/19/2002 | WO2002053534A8 Vla-4 inhibitors |
09/19/2002 | WO2002050028A3 Substituted benzoindoles as spla2 inhibitors |
09/19/2002 | WO2002024194A9 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
09/19/2002 | US20020133007 Potato and corn crops |
09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
09/19/2002 | US20020132792 Aryl-substituted indirubin derivatives, their production and use |
09/19/2002 | DE10112882A1 Selective cytostatic treatment of serotonin-producing tumors, using non-toxic tryptophan derivatives, e.g. 7-hydroxytryptophan, which are enzymatically converted into specific toxins in the tumor cells |
09/19/2002 | DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
09/18/2002 | EP1240157A2 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
09/18/2002 | EP1240154A1 Serine protease inhibitors |
09/18/2002 | EP1036059B1 Adamantane derivatives |
09/18/2002 | EP0994854B1 Method for preparing a substituted perhydroisoindole |
09/18/2002 | EP0975594B1 Process for the production of indole derivatives |
09/18/2002 | EP0888322B1 Electrophilic ketones for the treatment of herpesvirus infections |
09/18/2002 | EP0837847B1 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
09/18/2002 | EP0700388B1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
09/18/2002 | CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones |
09/18/2002 | CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications |
09/18/2002 | CN1091097C Process for preparing N-substuted glacinic acids or glycinic esters |
09/17/2002 | US6452004 Useful as an intermediate of a carbocyclic nucleoside usefully used as an anti-viral agent |
09/17/2002 | US6451843 Arylphenyl-substituted cyclic keto enols |
09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
09/17/2002 | US6451839 Indole sPLA2 inhibitors |
09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
09/17/2002 | US6451829 Coumarinic compounds having IgE affecting properties |
09/17/2002 | US6451827 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
09/17/2002 | US6451819 Pyrrolidine-3-yl-sulfanyl, or sufonyl or sufinyl derivatives used in the treatment of neurodegenerative diseases |
09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
09/17/2002 | US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
09/17/2002 | US6451724 Bis(n-methyl-5,10-dihydroindeno(1,2-b)indol-10 -yl)titanium dichloride |
09/17/2002 | US6451461 Hole transporting compounds having good thermal stability for organic electroluminescent device and method for production thereof |
09/17/2002 | CA2057338C Diarylfluoromethane compounds |
09/17/2002 | CA2048096C N-benzyl-indoles |
09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
09/12/2002 | WO2002070478A1 Indolone derivatives having vascular-damaging activity |
09/12/2002 | WO2002070477A1 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate therefor |
09/12/2002 | WO2002070468A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
09/12/2002 | WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
09/12/2002 | WO2002070464A2 Hydrazones and their therapeutic use |
09/12/2002 | WO2002070439A2 Amination process |
09/12/2002 | WO2002069947A2 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer |
09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
09/12/2002 | WO2002050030A3 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases |
09/12/2002 | WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses |
09/12/2002 | WO2001045681A3 Naphthoquinone derivatives as cd45 inhibitors |
09/12/2002 | WO2001012600A9 INHIBITORS OF FACTOR Xa |
09/12/2002 | US20020128510 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines |
09/12/2002 | US20020128499 Alkylthio-substituted benzoquinones by oxidizing with an alkali periodate in the presense of a phase transfer catalyst; Protective agents for rubber vulcanizates; aging and ozone resistance; fatigue; stabilizers |
09/12/2002 | US20020128490 Amination process |
09/12/2002 | US20020128483 Sulfonamide-containing indole compounds |
09/12/2002 | US20020128480 Pyrimidinesulfonamide containing indole compounds used as antiangiogenic and antitumor agents |
09/12/2002 | US20020128315 Amidinophenol derivatives as leukotriene B4 (LTB4)antagonists, phospholipase A2 inhibitors, and trypsin inhibitors. |
09/12/2002 | US20020128274 Benzylpiperazinyl-indolinylethanones |
09/12/2002 | US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders. |
09/12/2002 | US20020128261 Cyclohepta [b] [1,4] diazepino [6,7, 1-hi] indoles and derivatives |
09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
09/12/2002 | US20020128247 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents |
09/12/2002 | US20020128236 Substituted fused pyrroleoximes and fused pyrazoleoximes |
09/12/2002 | US20020128206 Such as 6-Amino-2-(2-((1-benzenesulfonyl-piperidine-4-carbonyl)-amino)-3-(1H-indol-3-yl)-propionylamino)-hexanoic acid tert-butyl ester for promotes secretion of growth hormone; gene expression |
09/12/2002 | US20020128149 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst |
09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
09/12/2002 | CA2434601A1 Methods for specifically inhibiting histone deacetylase-4 |
09/11/2002 | EP1238973A1 Novel substituted tricyclic compounds |
09/11/2002 | EP1238972A1 Novel carbazole derivative and chemically amplified radiation-sensitive resin composition |
09/11/2002 | EP1238971A1 Substituted guanidine derivatives |
09/11/2002 | EP1238704A2 Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst |
09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
09/11/2002 | EP1237879A1 Phenoxy and thiophenoxy acrylic acid compounds as herbicides |
09/11/2002 | EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
09/11/2002 | CN1368960A Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
09/11/2002 | CN1368883A Method for reducing serum glucose and trigluceride and inhibiting vascular formation by indolealkanoic acids |
09/11/2002 | CN1090632C Intermediates for preparation of duocarmycin SA and derivatives thereof, and process for production of intermdiates |
09/10/2002 | USRE37839 Fungicides, insecticides, miticides, nematocides, and pesticides |
09/10/2002 | US6448413 17-hydroxy-17-methyl-1,3-seco-2-nor-5-androstane-3-acid derivatives from mestanolone and aromatic nitro-aldehyde |
09/10/2002 | US6448412 Combinatorial chemistry libraries |
09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |